Temporomandibular Disorders Clinical Trial
Official title:
Effects of Mandibular Exercises Effect in Pain Perception and Sensitivity in Women With Myofascial Pain, a Double Blind Randomized Clinical Trial.
Verified date | November 2017 |
Source | Universidad Nacional Andres Bello |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The effectiveness of mandibular exercises as a treatment of muscular Orofacial Pain is yet unknown. This study hypothesized that training exercises can be an effective therapy improving pain perception.
Status | Completed |
Enrollment | 45 |
Est. completion date | December 30, 2016 |
Est. primary completion date | December 6, 2016 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 26 Years |
Eligibility |
Inclusion Criteria: - Temporomandibular Myofascial pain diagnosis - Oral contraceptives consumption - Facial pain for at least 3 months (and at least 10 of the last 30 days at Visit 0) - Agrees to terms for continuing/discontinuing certain prescription/over-the-counter pain medications. Exclusion Criteria: - Other orofacial pain diagnosis - Oral surgery within 6 months - Treatment for pain management within past 30 days - Neurological or psychiatric disorders - Orthodontic treatment - History of pregnancy, pregnancy or breastfeeding. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Universidad Nacional Andres Bello |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in the weekly mean subjective pain index after 21 days of treatment | Weekly mean subjective pain computed as the arithmetic mean of daily pain subjective values (visual analog scale - VAS) in Visit 1and prior to each study visit. Daily pain index is computed as pain intensity (0-100 numeric rating scale where 0 = "no pain" and 100 = "the most intense pain imaginable") for the different muscular sites tested. | Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days) | |
Primary | Change in the weekly mean pressure pain threshold (PPT) after 21 days of treatment | Weekly mean pressure pain threshold is computed as the arithmetic mean of daily pressure pain threshold values for muscular sites in Visit 1and prior to each study visit. Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days) | |
Primary | Change in the weekly mean pressure pain tolerance (PPTol) after 21 days of treatment | Weekly mean pressure pain tolerance is computed as the arithmetic mean of daily pressure pain tolerance values for muscular sites in Visit 1and prior to each study visit. Plot is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied per anatomical muscle site. | Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days) | |
Secondary | Change in pressure pain threshold at temporalis muscle after 1 week of treatment | Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between) | |
Secondary | Change in pressure pain threshold at temporalis muscle after 2 weeks of treatment | Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 2 (study day 14) ( 7 days in between) | |
Secondary | Change in pressure pain threshold at temporalis muscle after 3 weeks of treatment | Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 2 (study day 21) ( 7 days in between) | |
Secondary | Change in pressure pain threshold at masseter muscle after 1 week of treatment | Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between) | |
Secondary | Change in pressure pain threshold at masseter muscle after 2 weeks of treatment | Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between) | |
Secondary | Change in pressure pain threshold at masseter muscle after 3 weeks of treatment | Pressure values, measured in kilogram-force (kgf), from up to 3 experimental pressure stimuli, bilaterally applied to the area of t masseter muscle, will be averaged to obtain a single pressure pain threshold value per anatomical site. | Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between) | |
Secondary | Change in pressure pain tolerance at temporalis muscle after 1 week of treatment | Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle. | Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between) | |
Secondary | Change in pressure pain tolerance at temporalis muscle after 2 weeks of treatment | Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle. | Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between) | |
Secondary | Change in pressure pain tolerance at temporalis muscle after 3 weeks of treatment | Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of temporalis muscle. | Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between) | |
Secondary | Change in pressure pain tolerance at masseter muscle after 1 week of treatment | Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle. | Visit 1 (study day 0) and Visit 2 (study day 7) ( 7 days in between) | |
Secondary | Change in pressure pain tolerance at masseter muscle after 2 weeks of treatment | Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle. | Visit 1 (study day 0) and Visit 2 (study day 14) ( 14 days in between) | |
Secondary | Change in pressure pain tolerance at masseter muscle after 3 weeks of treatment | Pressure pain tolerance is captured as a pressure value, measured in kilogram-force (kgf) in 1 experimental pressure stimuli, bilaterally applied to the area of masseter muscle. | Visit 1 (study day 0) and Visit 2 (study day 21) ( 21 days in between) | |
Secondary | Change in the Pittsburgh Sleep Quality Index (PSQI) global score after 21 days of treatment | The PSQI has 19 items grouped into 7 component scores, each weighted equally on a 0-3 scale. The 7 component scores are summed to obtain a global score, which has a range of 0-21. | Visit 1 (study day 0) and Visit 4 (study day 3) ( duration study 21 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02839967 -
Influence of Intraoral Photobiomodulation in Individuals With Temporomandibular Joint Dysfunction
|
N/A | |
Completed |
NCT01659840 -
Efficacy of Red and Infrared Lasers in Treatment of Temporomandibular Disorders
|
N/A | |
Recruiting |
NCT05720065 -
Peripheral TMD Pain Mechanisms and the Effect by Botulinum Toxin A
|
Phase 2 | |
Recruiting |
NCT03029494 -
Oxidative Stress and Opiorphin in Temporomandibular Disorders
|
N/A | |
Completed |
NCT05607823 -
Adding Core Stabilization Training to Manuel Therapy in Temporomandibular Disorders
|
N/A | |
Completed |
NCT04948320 -
Temporomandibular Dysfunction Affects Neck Disability, Headache, Anxiety, And Sleep Quality In Women: A Cross-Sectional Study
|
||
Recruiting |
NCT04726683 -
Dry Needling vs Injection in Patients With Temporomandibular Disorders
|
N/A | |
Completed |
NCT01201512 -
CONDOR Temporomandibular Muscle and Joint Disorders (TMJD) Survey
|
N/A | |
Completed |
NCT04098952 -
Effects of Electric Massage on the Cervical Region in Subjects Diagnosed With Temporomandibular Disorders
|
N/A | |
Terminated |
NCT05162027 -
Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE)
|
Phase 2 | |
Completed |
NCT03926767 -
Additional Effect of Pain Neuroscience Education to Orofacial and Neck Exercises in Temporomandibular Disorders
|
N/A | |
Recruiting |
NCT05902026 -
The BETY-Biopsychosocial Questionnaire (BETY-BQ) in Individuals With Temporomandibular Dysfunction-Related Headache
|
||
Completed |
NCT03736408 -
Frequency of Occurrence of the Pain Form of Temporomandibular Joint Dysfunction
|
||
Recruiting |
NCT04694274 -
Genetic Polymorphisms and Their Association With Temporomandibular Disorders
|
||
Recruiting |
NCT01544439 -
Occlusal Splint and Counseling to Temporomandibular Disorder
|
Phase 3 | |
Completed |
NCT02380105 -
Effectiveness of a Counseling Program for Temporomandibular Disorders (TMD) Treatment
|
N/A | |
Completed |
NCT01535378 -
Interest of Behavioural Reeducation in Dysfunctions of Masticatory Apparatus. Relations Between Parafunctions and Dysfunctions of Mastixatory Apparatus
|
N/A | |
Completed |
NCT02230371 -
Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles
|
Phase 4 | |
Recruiting |
NCT03990662 -
What Are the Clinical Factors Associated With a Significant Pain Reduction Following Physiotherapy in Patients With Temporomandibular Disorders?
|
||
Recruiting |
NCT05927545 -
Efficacy of Manuel Therapy and BETY in Patients With Temporomandibular Dysfunction Related Headache
|
N/A |